CX deem paclitaxel not dangerous, but establishing the "truth takes time" - Vascular News

CX deem paclitaxel not dangerous, but establishing the "truth takes time"  Vascular News

Delegates voted 67% against the notion "There was a demonstrable danger in any organ of the body attributed to circulating paclitaxel" at CX.



Comments

Post a Comment

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease    Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Read more